스탠다드 바이오툴스(LAB)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.73 (+0.19%), 시가총액 $0.38B, 52주 최저~최고 $0.88 ~ $1.68.
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time
스탠다드 바이오툴스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
스탠다드 바이오툴스의 현재 주가는 $0.73 (+0.19%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
스탠다드 바이오툴스의 시가총액은 약 $0.38B입니다.
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop ther